IMMP
Immutep Ltd ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$71.83M
P/E Ratio
—
EPS
$-0.41
Beta
2.32
52W High
$3.32
52W Low
$0.29
50-Day MA
$1.27
200-Day MA
$1.90
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
7.13
PEG Ratio
—
About Immutep Ltd ADR
Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. The company is headquartered in Sydney, Australia.
Fundamentals
| Revenue (TTM) | $7.92M |
| Gross Profit (TTM) | $-74.78M |
| EBITDA | $-82.39M |
| Operating Margin | -764.00% |
| Return on Equity | -61.90% |
| Return on Assets | -32.10% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $0.48 |
| Price-to-Book | 1.09 |
| Price-to-Sales (TTM) | 9.07 |
| EV/Revenue | 1.645 |
| EV/EBITDA | -2.94 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 91.50% |
| Shares Outstanding | $147.37M |
| Float | $1.23B |
| % Insiders | 0.01% |
| % Institutions | 2.01% |
Analyst Ratings
Consensus ($1.00 target)
2
HoldData last updated: 4/29/2026